Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment

  • Read more about Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment
US Patent 9,388,211
Filed on 2015-04-15

O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES

  • Read more about O2-SUBSTITUTED 1-[(2-CARBOXYLATO) PYRROLIDIN -1-YL] DIAZEN-1-IUM-1, 2-DIOLATES
Germany
10010885.1
Filed on 2010-09-27

Anti-podoplanin Antibodies And Methods Of Use

  • Read more about Anti-podoplanin Antibodies And Methods Of Use
US Application 14/726,959
Filed on 2015-06-01

METHODS FOR REDUCING CELLULAR SENESCENCE MEDIATED BY DNA DAMAGING AGENTS

  • Read more about METHODS FOR REDUCING CELLULAR SENESCENCE MEDIATED BY DNA DAMAGING AGENTS
US Application 14/661,686
Filed on 2015-03-18

Inhibition Of Plasminogen Activator Inhibitor-1 (PAI-1) Activity Mitigates Radiation Fibrosis

  • Read more about Inhibition Of Plasminogen Activator Inhibitor-1 (PAI-1) Activity Mitigates Radiation Fibrosis
Patent Cooperation Treaty
PCT/US14/048604
Filed on 2014-07-29

Use Of Argon As A Tissue Fixation Preservative

  • Read more about Use Of Argon As A Tissue Fixation Preservative
US Patent 9,714,409
Filed on 2015-02-17

USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS

  • Read more about USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS
US Patent 9,644,179
Filed on 2014-05-21

Use of PDL1 Expressing Cells to Convert T Cells Into Regulatory Cells

  • Read more about Use of PDL1 Expressing Cells to Convert T Cells Into Regulatory Cells
European Patent
12851070.8
Filed on 2012-11-20

YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS

  • Read more about YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS
New Zealand
711188
Filed on 2015-08-18

The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer

  • Read more about The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer
US Patent 9,623,097
Filed on 2015-10-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 618
  • Page 619
  • Page 620
  • Page 621
  • Page 622
  • Page 623
  • Page 624
  • Page 625
  • Page 626
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health